Mette Staehr

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Pseudomonas Aeruginosa

Mesenchymal Stem Cells

Multiple Myeloma

Top Venues

Science translational medicine

Cancer immunology research

Blood cancer discovery

Sloan Kettering Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sloan Kettering Institute Dec 12 2016

United States

Research Technician, Sr :: Brentjens research

Publications

Carlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, Khong Y Ng, Yunxin Chen, William D Godfrey, Terence J Purdon, Vladimir Ponomarev, Hans-Guido Wendel, Renier J Brentjens, Eric L Smith
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma. Blood cancer discovery 1 (2) (2022)
Eric L Smith, Kim Harrington, Mette Staehr, Reed Masakayan, Jon Jones, Thomas J Long, Khong Y Ng, Majid Ghoddusi, Terence J Purdon, Xiuyan Wang, Trevor Do, Minh Thu Pham, Jessica M Brown, Carlos Fernandez De Larrea, Eric Olson, Elizabeth Peguero, Pei Wang, Hong Liu, Yiyang Xu, Sarah C Garrett-Thomson, Steven C Almo, Hans-Guido Wendel, Isabelle Riviere, Cheng Liu, Blythe Sather, Renier J Brentjens
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells. Science translational medicine 11 (485) (2020)
Eric L Smith, Sham Mailankody, Mette Staehr, Xiuyan Wang, Brigitte Senechal, Terence J Purdon, Anthony F Daniyan, Mark Blaine Geyer, Aaron D Goldberg, Elena Mead, Bianca D Santomasso, Jonathan Landa, Andreas Rimner, Isabelle Riviere, Ola Landgren, Renier J Brentjens
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy. Cancer immunology research 7 (7) (2019)